Abilify

Each year, nearly a million Americans are prescribed Abilify to treat mental disorders such as schizophrenia, bipolar disorder and major depression. The drug is designed to target dopamine, which is the body’s organic compound that controls its “reward seeking center.” While the goal is to alleviate psychological issues interfering with a stable life, medical research has linked Abilify to several serious side effects that can ruin lives and often requires professional help to control.

The creators of Abilify, Otsuka Pharma and Bristol Meyers, are one of the only drugs on the market targeting dopamine. These companies have an obligation to inform the public of any and all known side effects caused by using this drug.  While Abilify’s warning label lists some side effects, it fails to mention the side effects that are the most serious.

SERIOUS ABILIFY SIDE EFFECTS

  • Uncontrollable Hyper-sexual Activity
  • Compulsivity
  • Uncontrollable Gambling

Medical research has found that there is a direct correlation between the use of Abilify and one or more of the serious side effects given above. So much so, that when a person is on the drug the excessive behavior is exhibited, however, when that person is off the drug, the behavior does not exist. Some examples include gambling away a family’s life savings where no gambling habit existed prior to the use of this drug. Another is compulsive behavior such as spending thousands and thousands of dollars on needless or repetitive items. Some patients in faithful loving relationships have inexplicably taken on multiple sexual partners, thus ruining their relationships and family life. Again, these behaviors only occur while on Abilify; they did not exist prior to the use of, or after the cessation of, Abilify.

LAWSUIT BASES

Otsuka Pharma and Bristol Meyers, the manufacturers of Abilify, marketed and sold this drug without disclosing the above known and very serious side effects. The negligent actions exhibited by these two companies are in direct breach of its duties to inform patients about the known dangers of taking Abilify. The companies’ failure to warn patients of all side effects stole Patients’ ability to make a fully informed decision as to whether the risks of Abilify outweighed the potential benefits.

Johnson Law Group believes that if Otsuka Pharma and Bristol Meyers would have informed the public of the serious, harmful and life altering side effects of Abilify then no drug (or potentially a different drug) would have been used to treat the patient’s complaints. The company’s failure to warn, the mislabeling of the drug and its breach of duty is why we believe that you deserve to be compensated. If you or a loved one has been affected by Abilify, you may have a claim. Our Abilify attorneys will fight to get you the money you deserve. Consultations are free and confidential.